Papers Citing AGRE - 2004
<< Return to the AGRE main page
2005 | 2004 | 2003 | 2002
|
2001
Talebizadeh Z, Bittel DC, Veatch OJ, Butler MG, Takahashi TN, Miles JH.
Do known mutations in neuroligin genes (NLGN3 and NLGN4) cause autism?
PMID: 15679194
J Autism Dev Disord. 2004 Dec;34(6):735-6.
Summary by AGRE's Researcher Liaison Vlad Kustanovich Ph.D.:
A group of scientists, known as the PARIS group, have identified a genetic association between autism and two neuroligin genes. Since then, several other groups have tried to understand the involvement of these genes in autism.
There are compelling reasons why these are attractive candidate genes. Neuroligin proteins play critical roles in the process of creating and maintaining connections in the brain, a process known as synaptogenesis.
Further research has shown these genes are found on the X chromosome, which would explain why there is such a remarkable male bias in affected children.
To determine whether these genes are generally involved - or were specific to the families in the previous studies - Dr. Talebizadeh and colleagues tested for the presence of the mutations within the AGRE families, as well as from the University of Missouri-Columbia Hospital.
The mutations previously identified were not present in the study population. While the sample size in this study was fairly small (67 families), it indicates that the mutations identified by the PARIS group do not appear to be generally involved in the autistic United States populations.
There has been a flurry of research into chromosome 2q after several reports indicated a genetic link to autism at the chromosome 2q region. Two additional reports identified a subset of families that showed a more striking level of linkage in this area. The autistic children in these families were notable because they had a more pronounced difficulty speaking in phrases rather than single words.
There are a large number of genes that appear to be promising candidates for influencing autism susceptibility. A group of scientists at Duke University, the W.S. Hall Psychiatric Institute and Vanderbilt University, sought to replicate these linkage findings.
While the findings were not overwhelming, there was evidence linked to the 2q region. To bolster their findings, the researchers added 99 AGRE families to their data sets and examined specific candidate genes in the 2q region.
The researchers selected genetic changes (variants) in nine genes in this region that appeared to be candidates. Some genes, such as GAD1 and HOXD1, are involved in the functioning and development of the nervous system. Others, such as CD28 and CTLA4, play a role in the operation of the immune system.
A study was conducted with each gene, as well as its genetic variants, to determine if there is a connection between the transmission of the genetic changes from parent to affected child.
Of the families tested, only three genes showed mild association with autism. Two of the three genes (DLX6 and HOXD1) are involved in the development of the nervous system. The third gene, ABI2, is also believed to play a role in synaptic pruning, whereby the excess nerve cells are removed from the brain.
Despite these modest associations, researchers admitted it is not likely that any of these genes play major roles in autism susceptibility. However, they may still be involved as modifiers of major genes that contribute to autism susceptibility.
Several genome-wide scans of autism identified a region on the long arm of chromosome 7 as a likely site where an autism susceptibility gene may reside. Among the most promising candidate genes in this region is the gene RELN (pronounced reelin).
RELN encodes a protein that is crucial to the formation of connections among brain cells. This protein also plays a role in the early development of the brain by controlling where and how the brain cells orient themselves.
To further explore the potential association of RELN with autism, scientists at Duke University, Vanderbilt University and Tufts, collaborated by pooling their families with those from the AGRE collection.
These researchers examined the transmission rates of specific genetic variants from parents to affected children. The variants serve as a way to monitor the transmission of gene forms at particular points in the DNA. Five variants in the RELN were tested, as well as a few in two genes that are situated on either side of RELN. Two genetic markers in RELN were shown to be associated with autism. None of the genetic markers in the surrounding genes showed any evidence of association.
The scientists then examined the contribution of each family set to the association between RELN and autism. Interestingly, they found that the AGRE families disproportionately contributed the most significant association, while Duke and Tufts families contributed to a lesser extent.
This demonstrates the variability that can occur between studies when an association is found and then refuted. There are many reasons for this variability. One is the potential difference in the underlying causes of autism on a systemic level. Another possibility is mutations at the DNA level.
For this reason, geneticists attempt to study as many families with autism as possible to validate their results. With a greater number of family samples, geneticists can study families with autism in groups based on potential biological factors, without eroding the statistical significance of their findings.